Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.74
-0.50 (-6.91%)
Mar 5, 2026, 12:52 PM EST - Market open

Lexeo Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for Lexeo Therapeutics stock have an average target of 18.6, with a low estimate of 10 and a high estimate of 30. The average target predicts an increase of 175.96% from the current stock price of 6.74.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $18.6 $20 $30
Change +48.37% +175.96% +196.74% +345.10%
* Price targets were last updated on Jan 13, 2026.

Analyst Ratings

The average analyst rating for Lexeo Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Sep '25Oct '25Nov '25Dec '25Jan '26Feb '26
Strong Buy 344555
Buy 445555
Hold 000000
Sell 000000
Strong Sell 000000
Total 789101010

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$17
Strong Buy Maintains $17 +152.23% Jan 13, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$13$10
Strong Buy Maintains $13$10 +48.37% Jan 13, 2026
Raymond James
Raymond James
Strong Buy
Initiates
$25
Strong Buy Initiates $25 +270.92% Dec 18, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$17
Strong Buy Maintains $17 +152.23% Dec 11, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$19
Buy Initiates $19 +181.90% Dec 1, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.01
from -3.09
EPS Next Year
-1.55
from -2.01
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
518.48K1.66M654.00K----
Revenue Growth
-219.59%-60.53%----
EPS
-3.57-32.60-36.36-12.40-3.09-2.01-1.55
EPS Growth
-------
Forward PE
-------
No. Analysts -----1312
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027202820292030
High -1.90 -1.08
Avg -2.01 -1.55
Low -2.21 -2.31

EPS Growth

EPS Growth 202520262027202820292030
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.